SCD and metabolic dysfunction-associated steatotic liver disease: Increasing research demonstrated that suppressed SCD-1 expression and enzyme activity or SCD-1 knock out to make a great contribution to NAFLD amelioration (Ntambi et al., 2002; Biddinger et al., 2006; Miyazaki et al., 2007; Sampath et al., 2009).